Burjassot

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Macular degeneration

Closed trials

• Completed

  GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

  NCT03815825· Phase 2· Ionis Pharmaceuticals, Inc.· Source